The Asia Pacific Wound Debridement Market should witness market growth of 6.0% CAGR during the forecast period (2022-2028).
The increasing incidences of skin infections and burn injuries have increased the demand for wound debridement processes. In addition, the rising incidences of injuries and accidents that occurred during adventures, sports, and travel have also necessitated the requirement of wound debridement procedures. Severe accidents can also result in trauma cases, thereby requiring immediate medical attention.
Such injuries lead to acute wound formations, which need advanced procedures and medication for treatment. In the event of a lack of care and attention to acute wound treatment, situations may propel the transformation of these wounds into chronic wounds. This significantly increases the overall chronic wound burden along with the rise in the health care burden.
The rising chronic diseases’ prevalence, surging adoption of products and techniques used in debridement, and increase in the population of patients are additional factors that have necessitated the application and evolvement of the wound debridement processes. In recent years, some vital developments in the products used in the wound debridement process have simplified the healing process.
In the Asia Pacific region, the improving healthcare infrastructure, rising geriatric population, and the presence of a significantly more significant patient base aid in the increasing demand for wound management products. In most developing countries of the region, the difference in the prevalence of prediabetes and diabetes between the rural and urban regions is narrowing. This is mainly because of the increasing reach of western lifestyle influences and other behavioral changes.
The China market dominated the Asia Pacific Wound Debridement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $464.7 million by 2028. The Japan market is estimated to grow a CAGR of 5.3% during (2022-2028). Additionally, The India market would experience a CAGR of 6.6% during (2022-2028).
Based on Mode of Purchase, the market is segmented into Prescription, Over The Counter and Others. Based on Product, the market is segmented into Medical Gauzes, Gels, Surgical Devices, Ultrasonic Devices, Ointments & Creams and Others. Based on Method, the market is segmented into Surgical, Autolytic, Enzymatic, Mechanical and Others. Based on Wound Type, the market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Burn Wounds and Venous Leg Ulcers & Others. Based on End-use, the market is segmented into Hospitals, Homecare and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Coloplast Group, Medline Industries, Inc., Smith & Nephew PLC, Medtronic PLC, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.), Johnson & Johnson (Ethicon, Inc.), Baxter International, Inc., and Molnlycke Health Care AB.
The increasing incidences of skin infections and burn injuries have increased the demand for wound debridement processes. In addition, the rising incidences of injuries and accidents that occurred during adventures, sports, and travel have also necessitated the requirement of wound debridement procedures. Severe accidents can also result in trauma cases, thereby requiring immediate medical attention.
Such injuries lead to acute wound formations, which need advanced procedures and medication for treatment. In the event of a lack of care and attention to acute wound treatment, situations may propel the transformation of these wounds into chronic wounds. This significantly increases the overall chronic wound burden along with the rise in the health care burden.
The rising chronic diseases’ prevalence, surging adoption of products and techniques used in debridement, and increase in the population of patients are additional factors that have necessitated the application and evolvement of the wound debridement processes. In recent years, some vital developments in the products used in the wound debridement process have simplified the healing process.
In the Asia Pacific region, the improving healthcare infrastructure, rising geriatric population, and the presence of a significantly more significant patient base aid in the increasing demand for wound management products. In most developing countries of the region, the difference in the prevalence of prediabetes and diabetes between the rural and urban regions is narrowing. This is mainly because of the increasing reach of western lifestyle influences and other behavioral changes.
The China market dominated the Asia Pacific Wound Debridement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $464.7 million by 2028. The Japan market is estimated to grow a CAGR of 5.3% during (2022-2028). Additionally, The India market would experience a CAGR of 6.6% during (2022-2028).
Based on Mode of Purchase, the market is segmented into Prescription, Over The Counter and Others. Based on Product, the market is segmented into Medical Gauzes, Gels, Surgical Devices, Ultrasonic Devices, Ointments & Creams and Others. Based on Method, the market is segmented into Surgical, Autolytic, Enzymatic, Mechanical and Others. Based on Wound Type, the market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Burn Wounds and Venous Leg Ulcers & Others. Based on End-use, the market is segmented into Hospitals, Homecare and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Coloplast Group, Medline Industries, Inc., Smith & Nephew PLC, Medtronic PLC, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.), Johnson & Johnson (Ethicon, Inc.), Baxter International, Inc., and Molnlycke Health Care AB.
Scope of the Study
By Mode of Purchase
- Prescription
- Over The Counter
- Others
By Product
- Medical Gauzes
- Gels
- Surgical Devices
- Ultrasonic Devices
- Ointments & Creams
- Others
By Method
- Surgical
- Autolytic
- Enzymatic
- Mechanical
- Others
By Wound Type
- Diabetic Foot Ulcers
- Pressure Ulcers
- Burn Wounds
- Venous Leg Ulcers & Others
By End-use
- Hospitals
- Homecare
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- 3M Company
- Coloplast Group
- Medline Industries, Inc.
- Smith & Nephew PLC
- Medtronic PLC
- ConvaTec Group PLC
- Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.)
- Johnson & Johnson (Ethicon, Inc.)
- Baxter International, Inc.
- Molnlycke Health Care AB
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Wound Debridement Market, by Mode of Purchase
1.4.2 Asia Pacific Wound Debridement Market, by Product
1.4.3 Asia Pacific Wound Debridement Market, by Method
1.4.4 Asia Pacific Wound Debridement Market, by Wound Type
1.4.5 Asia Pacific Wound Debridement Market, by End-use
1.4.6 Asia Pacific Wound Debridement Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Asia Pacific Wound Debridement Market by Mode of Purchase
4.1 Asia Pacific Prescription Market by Country
4.2 Asia Pacific Over The Counter Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Wound Debridement Market by Product
5.1 Asia Pacific Medical Gauzes Market by Country
5.2 Asia Pacific Gels Market by Country
5.3 Asia Pacific Surgical Devices Market by Country
5.4 Asia Pacific Ultrasonic Devices Market by Country
5.5 Asia Pacific Ointments & Creams Market by Country
5.6 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Wound Debridement Market by Method
6.1 Asia Pacific Surgical Market by Country
6.2 Asia Pacific Autolytic Market by Country
6.3 Asia Pacific Enzymatic Market by Country
6.4 Asia Pacific Mechanical Market by Country
6.5 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Wound Debridement Market by Wound Type
7.1 Asia Pacific Diabetic Foot Ulcers Market by Country
7.2 Asia Pacific Pressure Ulcers Market by Country
7.3 Asia Pacific Burn Wounds Market by Country
7.4 Asia Pacific Venous Leg Ulcers & Others Market by Country
Chapter 8. Asia Pacific Wound Debridement Market by End-use
8.1 Asia Pacific Hospitals Market by Country
8.2 Asia Pacific Homecare Market by Country
8.3 Asia Pacific Others Market by Country
Chapter 9. Asia Pacific Wound Debridement Market by Country
9.1 China Wound Debridement Market
9.1.1 China Wound Debridement Market by Mode of Purchase
9.1.2 China Wound Debridement Market by Product
9.1.3 China Wound Debridement Market by Method
9.1.4 China Wound Debridement Market by Wound Type
9.1.5 China Wound Debridement Market by End-use
9.2 Japan Wound Debridement Market
9.2.1 Japan Wound Debridement Market by Mode of Purchase
9.2.2 Japan Wound Debridement Market by Product
9.2.3 Japan Wound Debridement Market by Method
9.2.4 Japan Wound Debridement Market by Wound Type
9.2.5 Japan Wound Debridement Market by End-use
9.3 India Wound Debridement Market
9.3.1 India Wound Debridement Market by Mode of Purchase
9.3.2 India Wound Debridement Market by Product
9.3.3 India Wound Debridement Market by Method
9.3.4 India Wound Debridement Market by Wound Type
9.3.5 India Wound Debridement Market by End-use
9.4 South Korea Wound Debridement Market
9.4.1 South Korea Wound Debridement Market by Mode of Purchase
9.4.2 South Korea Wound Debridement Market by Product
9.4.3 South Korea Wound Debridement Market by Method
9.4.4 South Korea Wound Debridement Market by Wound Type
9.4.5 South Korea Wound Debridement Market by End-use
9.5 Singapore Wound Debridement Market
9.5.1 Singapore Wound Debridement Market by Mode of Purchase
9.5.2 Singapore Wound Debridement Market by Product
9.5.3 Singapore Wound Debridement Market by Method
9.5.4 Singapore Wound Debridement Market by Wound Type
9.5.5 Singapore Wound Debridement Market by End-use
9.6 Malaysia Wound Debridement Market
9.6.1 Malaysia Wound Debridement Market by Mode of Purchase
9.6.2 Malaysia Wound Debridement Market by Product
9.6.3 Malaysia Wound Debridement Market by Method
9.6.4 Malaysia Wound Debridement Market by Wound Type
9.6.5 Malaysia Wound Debridement Market by End-use
9.7 Rest of Asia Pacific Wound Debridement Market
9.7.1 Rest of Asia Pacific Wound Debridement Market by Mode of Purchase
9.7.2 Rest of Asia Pacific Wound Debridement Market by Product
9.7.3 Rest of Asia Pacific Wound Debridement Market by Method
9.7.4 Rest of Asia Pacific Wound Debridement Market by Wound Type
9.7.5 Rest of Asia Pacific Wound Debridement Market by End-use
Chapter 10. Company Profiles
10.1 Medtronic PLC
10.1.1 Company overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.6 SWOT Analysis
10.2 ConvaTec Group PLC
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Product Category and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Acquisitions and Mergers:
10.2.5.3 Product Launches and Expansions:
10.3 Coloplast Group
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.4 3M Company
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Acquisitions and Mergers:
10.5 Smith & Nephew PLC
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Geographical Expansions:
10.5.5.2 Acquisitions and Mergers:
10.6 Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.7 Baxter International, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Acquisition and Mergers:
10.8 Johnson & Johnson (Ethicon, Inc.)
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental &Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Acquisition and Mergers:
10.9 Medline Industries, Inc.
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
10.10. Molnlycke Health Care AB
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Partnerships, Collaborations, and Agreements:
Companies Mentioned
- 3M Company
- Coloplast Group
- Medline Industries, Inc.
- Smith & Nephew PLC
- Medtronic PLC
- ConvaTec Group PLC
- Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.)
- Johnson & Johnson (Ethicon, Inc.)
- Baxter International, Inc.
- Molnlycke Health Care AB
Methodology
LOADING...
